Clinical research of the relationship between 5-lipoxygenase activating protein gene polymorphism and cerebral infarction susceptibility
10.3760/cma.j.issn.1008-1372.2016.02.014
- VernacularTitle:5-脂氧合酶激活蛋白基因多态性与脑梗死易患性的临床研究
- Author:
Xuewen FENG
;
Weilin WU
;
Chunyou CHEN
;
Chenfeng QIU
;
Xianjun BAO
- Publication Type:Journal Article
- Keywords:
Arachidonate 5-1ipoxygenase/BI/GE;
Polymorphism,genetic;
Brain infarction/GE
- From:
Journal of Chinese Physician
2016;18(2):212-215
- CountryChina
- Language:Chinese
-
Abstract:
Objective To investigate the expression of 5-lipoxygenase activating protein gene (ALOX5AP) polymorphism in the patients with cerebral infarction,and explore its relationship with cerebral infarction susceptibility.Methods Patients with cerebral infarction and healthy volunteers were selected for this study,whose venous blood was extracted and detected with polymerase chain reaction/restriction fragment length polymorphism (PCR-RFLP).Haplotype A (SG13S114T,SG13S89G,SG13S32A,SG13S25G),haplotype B (SG13S377A,SG13S114A,SG13S41A,SG13S35G),and their nucleotide polymorphism loci were observed.Results Single nucleotide polymorphism (SNP)-SG13S114,SNP-SG13S32 and HapA carrying rate were significantly different between patients with cerebral infarction and healthy volunteers (P <0.05).SNP-SG13S114 and SNP-SG13S32 were independent risk factors of cerebral infarction (OR > 1.0,P < 0.05).Conclusions The morbidity of cerebral infarction in Wenling City was influenced by SNP-SG13S114,SNP-SG13S32,and HapA carrying rate.